Research progress in bladder cancer
Abstract
Keywords
Full Text:
PDFReferences
Torre LA, Bray F, Siegel RL, et al., 2015, Global Cancer Statistics, 2012. CA Cancer J Clin, 65(2):87-108.
Antoni S, Ferlay J, Soerjomataram I, et al., 2016, Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol, 71:96-108. DOI 10.1016/j. eururo.2016.06.010.
Sujun H, Sizhi Z, Wanqing C, et al., 2013, Analysis of the Current Status and Epidemic Trends of Bladder Cancer in China. Cancer Prog, 11(1):89-95.
Wanqing C, Rongshou Z, Sizhi Z, et al., 2016, Analysis of the Incidence and Mortality of Malignant Tumors in China in 2012. Chin J Tumor, 25(1):1-8.
Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al., 2007, Epidemiology of Urinary Bladder Cancer: From Tumor Development to Patient’s Death. World J Urol, 25(3):285-95. DOI 10.1007/s00345-007-0168-5.
Zhang H, Guo Y, Song Y, et al., 2016, Long Noncoding RNA GAS5 Inhibits Malignant Proliferation and Chemotherapy Resistance to Doxorubicin in Bladder Transitional Cell Carcinoma. Cancer Chemother Pharmacol, 79(1):49-55. DOI 10.1007/s00280-016-3194-4.
Kamat AM, Hahn NM, Efstathiou JA, et al., 2016, Bladder Cancer. Lancet, 388(10061):2796-810. DOI 10.1016/ s0140-6736(16)30512-8.
Babjuk M, Bohle A, Burger M, et al., 2016, EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol, 71(3):447-61. DOI 10.1016/j.eururo.2016.11.030.
Bi L, Huang H, Fan X, et al., 2014, Extended vs Non-extended Pelvic Lymph Node Dissection and their Influence on Recurrence-free Survival in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-analysis of Comparative Studies. BJU Int, 113(5b):E39-E48. DOI 10.1111/bju.12371.
Zargar H, Espiritu PN, Fairey AS, et al., 2015, Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol, 67(2):241-49.
Galsky MD, Pal SK, Chowdhury S, et al., 2015, Comparative Effectiveness of Gemcitabine Plus Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Cancer, 121(15):2586-93. DOI 10.1002/cncr.29387.
Grossman HB, Natale RB, Tangen CM, et al., Neoadjuvant Chemotherapy Plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer. N Engl J Med, 349(9):859-66. DOI 10.1056/nejmoa022148.
Mankoff SP, Brander C, Ferrone S, et al., 2004, Lost in Translation: Obstacles to Translational Medicine. J Transl Med, 2(1):14.
Xia X, Jinming Z, Hong Z, et al., 2016, Practice and Thinking of Translational Medicine from the Perspective of Research-oriented Medicine. Chin J Hosp Manag 32(1):19-21.
Li C, Du Y, Yang Z, et al., 2016, GALNT1-Mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-renewal and Tumor-initiating Capacity of Bladder Cancer Stem Cells. Cancer Res, 76(5):1273-83. DOI 10.1158/0008-5472.can-15-2309.
Li C, Yang Z, Du Y, et al., 2014, BCMab1, a Monoclonal Antibody Against Aberrantly Glycosylated Integrin alpha3beta1, has Potent Antitumor Activity of Bladder Cancer in vivo. Clin Cancer Res, 20(15):4001-13. DOI 10.1158/1078-0432.ccr-13-3397.
Yang Z, Li C, Liu H, et al., 2016, Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells. Eur Urol, 71(1):8-12. DOI 10.1016/j.eururo.2016.06.025.
Yang Z, Wu S, Cai Z, et al., 2016, Reply from Authors Re: Xue-Ru Wu. Attention to Detail by Single-cell Sequencing. Eur Urol, 71(1):15-6. DOI 10.1016/j.eururo.2016.11.003.
DOI: http://dx.doi.org/10.18063/c+.v1i2.236
Refbacks
- There are currently no refbacks.
Copyright (c) 2019 Chong Li, Xue Tan, Fangjing Fan, Xu Zhang, Zhao Yang, Meiqing Wang

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Recent Articles | About Journal | For Author | Fees | About Whioce
Copyright © Whioce Publishing Pte Ltd. All Rights Reserved.